GlassScriptPhysician profile
Lisa M Kim
NPI 1982795753
$1,429.09
in general payments reported to CMS, 2019-2025
14 companies · $40.53 in 2025
The $40.53 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $610 · 2020: $219 · 2021: $212 · 2022: $56.92 · 2023: $265 · 2024: $25.11 · 2025: $40.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $330.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $246.06 | 2019-2021 | |
| Novo Nordisk INC | $236.75 | 2019-2022 | |
| Amgen INC. | $157.65 | 2019-2025 | Otezla, Repatha, Repatha |
| Lilly USA, LLC | $153.98 | 2022-2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $147.87 | 2019-2024 | Farxiga |
| Astellas Pharma US INC | $110.39 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.67 | 2020-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $97.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $70.12 | 2019-2021 | |
| Merz North America, INC. | $28.21 | 2021 | |
| Radius Health, INC. | $26.62 | 2025 | |
| Glaxosmithkline, LLC. | $19.59 | 2023 | Shingrix |
| Philips North America LLC | $18.86 | 2020 | |
| Merck Sharp & Dohme LLC | $13.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.